Pursuant to Rule 461 under the Securities Act of 1933, as amended, Black Bird Biotech, Inc. (the “Company”) respectfully requests that the Securities and Exchange Commission take such action as may be necessary and proper in order that the Registration Statement on Form S-1 (Registration No. 333-269630) (the “Registration Statement”), be declared effective at 3:00 p.m. (Washington, D.C. time), on April 4, 2023, or as soon thereafter as practicable.
Please call Eric Newlan at (940) 367-6154 to provide notice of the effectiveness of the Registration Statement.
Respectfully submitted,
/s/ Fabian G. Deneault
Fabian G. Deneault
President
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.